122 related articles for article (PubMed ID: 12826147)
1. Coadministration of tacrolimus and ketoconazole in renal transplant recipients: cost analysis and review of metabolic effects.
Soltero L; Carbajal H; Rodríguez-Montalvo C; Valdés A
Transplant Proc; 2003 Jun; 35(4):1319-21. PubMed ID: 12826147
[TBL] [Abstract][Full Text] [Related]
2. Co-administration of ketoconazole and tacrolimus to kidney transplant recipients: cost minimization and potential metabolic benefits.
Elamin S; El-Magzoub AR; Dablouk N; Mahmoud F; Abbas M
Saudi J Kidney Dis Transpl; 2014 Jul; 25(4):814-8. PubMed ID: 24969193
[TBL] [Abstract][Full Text] [Related]
3. Three-year posttransplant graft survival in renal-transplant patients with graft function at 6 months receiving tacrolimus or cyclosporine microemulsion within a triple-drug regimen.
Irish W; Sherrill B; Brennan DC; Lowell J; Schnitzler M
Transplantation; 2003 Dec; 76(12):1686-90. PubMed ID: 14688516
[TBL] [Abstract][Full Text] [Related]
4. Influence of tacrolimus plus mycophenolate mofetil regimens on acute rejection rate and diabetes mellitus development in renal transplant recipients.
Demirbaş A; Tuncer M; Yavuz A; Gürkan A; Kaçar S; Cetinkaya R; Tekin S; Akbaş SH; Akaydin M; Ersoy F; Yakupoğlu G
Transplant Proc; 2004; 36(1):175-7. PubMed ID: 15013338
[TBL] [Abstract][Full Text] [Related]
5. Co-administration of ketoconazole to tacrolimus-treated kidney transplant recipients: a prospective randomized study.
el-Dahshan KF; Bakr MA; Donia AF; Badr Ael-S; Sobh MA
Nephrol Dial Transplant; 2004 Jun; 19(6):1613-7. PubMed ID: 15034161
[TBL] [Abstract][Full Text] [Related]
6. Ketoconazole-tacrolimus coadministration in kidney transplant recipients: two-year results of a prospective randomized study.
El-Dahshan KF; Bakr MA; Donia AF; Badr Ael-S; Sobh MA
Am J Nephrol; 2006; 26(3):293-8. PubMed ID: 16804292
[TBL] [Abstract][Full Text] [Related]
7. Coadministration of ketoconazole and cyclosporine for kidney transplant recipients: long-term follow-up and study of metabolic consequences.
Sobh MA; Hamdy AF; El Agroudy AE; El Sayed K; El-Diasty T; Bakr MA; Ghoneim MA
Am J Kidney Dis; 2001 Mar; 37(3):510-7. PubMed ID: 11228175
[TBL] [Abstract][Full Text] [Related]
8. A randomized long-term trial of tacrolimus and sirolimus versus tacrolimus and mycophenolate mofetil versus cyclosporine (NEORAL) and sirolimus in renal transplantation. I. Drug interactions and rejection at one year.
Ciancio G; Burke GW; Gaynor JJ; Mattiazzi A; Roth D; Kupin W; Nicolas M; Ruiz P; Rosen A; Miller J
Transplantation; 2004 Jan; 77(2):244-51. PubMed ID: 14742989
[TBL] [Abstract][Full Text] [Related]
9. Immunosuppression with generic tacrolimus and mycophenolate mofetil in renal transplant recipients: preliminary report in Chile.
Müller H; Solari S; Zuñiga C; Pedreros C; Troncoso J; Morente C; Ovalle R; Acosta P; Chavez T; Albornoz E
Transplant Proc; 2008 Apr; 40(3):705-7. PubMed ID: 18454992
[TBL] [Abstract][Full Text] [Related]
10. The cost effectiveness of tacrolimus versus microemulsified cyclosporin: a 10-year model of renal transplantation outcomes.
Orme ME; Jurewicz WA; Kumar N; McKechnie TL
Pharmacoeconomics; 2003; 21(17):1263-76. PubMed ID: 14986738
[TBL] [Abstract][Full Text] [Related]
11. Sirolimus and ketoconazole co-prescription in renal transplant recipients.
Thomas PP; Manivannan J; John GT; Jacob CK
Transplantation; 2004 Feb; 77(3):474-5. PubMed ID: 14966432
[TBL] [Abstract][Full Text] [Related]
12. Safety and efficacy of tacrolimus in combination with mycophenolate mofetil (MMF) in cadaveric renal transplant recipients. FK506/MMF Dose-Ranging Kidney Transplant Study Group.
Miller J; Mendez R; Pirsch JD; Jensik SC
Transplantation; 2000 Mar; 69(5):875-80. PubMed ID: 10755543
[TBL] [Abstract][Full Text] [Related]
13. Two-year experience with tacrolimus in renal transplantation after late conversion from cyclosporine therapy.
Videla CO
Transplant Proc; 2009; 41(6):2659-63. PubMed ID: 19715995
[TBL] [Abstract][Full Text] [Related]
14. Clinical pharmacokinetics of tacrolimus after the first oral administration in combination with mycophenolate mofetil and prednisone in Chinese renal transplant recipients.
Chen YH; Zheng KL; Chen LZ; Dai YP; Fei JG; Qiu J; Li J
Transplant Proc; 2005 Dec; 37(10):4246-50. PubMed ID: 16387090
[TBL] [Abstract][Full Text] [Related]
15. Safety and efficacy of delayed introduction of low-dose tacrolimus in elderly recipients of cadaveric renal transplants from donors over 55 years of age.
Gentil MA; Osuna A; Capdevila L; Rodriguez-Algarra G; Cantarell C; Pereira P; González-Molina M;
Transplant Proc; 2003 Aug; 35(5):1706-8. PubMed ID: 12962766
[TBL] [Abstract][Full Text] [Related]
16. Steroid avoidance reduce the cost of morbidities after live-donor renal allotransplants: a prospective, randomized, controlled study.
Gheith OA; Nematalla AH; Bakr MA; Refaie A; Shokeir AA; Ghoneim MA
Exp Clin Transplant; 2011 Apr; 9(2):121-7. PubMed ID: 21453230
[TBL] [Abstract][Full Text] [Related]
17. Two doses of daclizumab with delayed introduction of low-dose tacrolimus in elderly recipients of cadaveric renal transplants from donors >55 years of age.
Osuna A; Gentil MA; Capdevila L; Cantarell C; Mazuecos A; Pereira P; Rodríguez-Algarra G; González-Molina M;
Transplant Proc; 2005 Apr; 37(3):1438-40. PubMed ID: 15866630
[TBL] [Abstract][Full Text] [Related]
18. Itraconazole prophylaxis in lung transplant recipients receiving tacrolimus (FK 506): efficacy and drug interaction.
Shitrit D; Ollech JE; Ollech A; Bakal I; Saute M; Sahar G; Kramer MR
J Heart Lung Transplant; 2005 Dec; 24(12):2148-52. PubMed ID: 16364864
[TBL] [Abstract][Full Text] [Related]
19. Annual trends and triple therapy--1991-2000.
Nishikawa K; Terasaki PI
Clin Transpl; 2001; ():247-69. PubMed ID: 12211788
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics of tacrolimus in adult renal transplant recipients.
Naik P; Madhavarapu M; Mayur P; Nayak KS; Sritharan V
Drug Metabol Drug Interact; 2012; 27(3):151-5. PubMed ID: 23089531
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
